TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | -2 | -3 | -7 | -23 | -18 | -11 | -10 |
| P | %wins | 50 | 50 | 0 | 0 | 50 | 0 | 25 | |||
| S | %ret | 1 | 1 | 1 | 1 | 5 | 20 | 20 | -17 | 0 | 6 |
| S | %wins | 0 | 0 | 0 | 0 | 100 | 100 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/22/16 14:55 | 6/20/16 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Welch James H | CA | O | CFO | P.m | 49 | 19.80 | 0 | 3 | New | 3 | D | -90 | -42 | -12 | 17 | 2 | -5 | -10 | 0 | -4 | -8 | -5 | -29 | -42 | ||
9/7/11 19:53 | 9/6/11 | ACRX | Acelrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Welch James H | CA | O | CFO | P.m | 33 | 3.34 | 0 | 10 | 200 | 15 | D | 2 | -31 | -24 | -9 | 2 | -7 | 0 | 3 | -8 | -16 | 6 | -11 | ||
9/3/04 17:53 | 9/2/04 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Welch James H | CA | O | CFO,VP,S | M.d | 10 | 1.80 | 5 | 6 | 4 | D | 8 | 132 | 9 | 18 | 54 | 0 | 3 | 1 | 1 | 5 | 20 | 20 | -17 | 0 | |
9/3/04 17:53 | 9/2/04 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Welch James H | CA | O | CFO,VP,S | S.d | -202 | 20.23 | 5 | -10 | -73 | 4 | D | 8 | 132 | 9 | 18 | 54 | 0 | 3 | 1 | 1 | 5 | 20 | 20 | -17 | 0 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |